Literature DB >> 23835579

Kidney cancer: creating a molecular atlas of clear cell renal cell carcinoma genetics.

Annette Fenner.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23835579     DOI： 10.1038/nrurol.2013.151

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Integrated molecular analysis of clear-cell renal cell carcinoma.

Authors:  Yusuke Sato; Tetsuichi Yoshizato; Yuichi Shiraishi; Shigekatsu Maekawa; Yusuke Okuno; Takumi Kamura; Teppei Shimamura; Aiko Sato-Otsubo; Genta Nagae; Hiromichi Suzuki; Yasunobu Nagata; Kenichi Yoshida; Ayana Kon; Yutaka Suzuki; Kenichi Chiba; Hiroko Tanaka; Atsushi Niida; Akihiro Fujimoto; Tatsuhiko Tsunoda; Teppei Morikawa; Daichi Maeda; Haruki Kume; Sumio Sugano; Masashi Fukayama; Hiroyuki Aburatani; Masashi Sanada; Satoru Miyano; Yukio Homma; Seishi Ogawa
Journal:  Nat Genet       Date:  2013-06-24       Impact factor: 38.330

2.  Comprehensive molecular characterization of clear cell renal cell carcinoma.

Authors: 
Journal:  Nature       Date:  2013-06-23       Impact factor: 49.962
  2 in total
  3 in total

1.  Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma.

Authors:  Yong Wu; Cong Tan; Wei-Wei Weng; Yu Deng; Qiong-Yan Zhang; Xiao-Qun Yang; Hua-Lei Gan; Tao Wang; Pei-Pei Zhang; Mi-Die Xu; Yi-Qin Wang; Chao-Fu Wang
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

Review 2.  Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism.

Authors:  Ming Yang; Huizhong Su; Tomoyoshi Soga; Kamil R Kranc; Patrick J Pollard
Journal:  Hypoxia (Auckl)       Date:  2014-08-30

3.  Analysis on Inpatient Health Expenditures of Renal Cell Carcinoma in a Grade-A Tertiary Hospital in Beijing.

Authors:  Xin Liu; Yong-Hui Mao; Xue-Mei He; Yan-Jing Zhang; Ying Sun
Journal:  Chin Med J (Engl)       Date:  2017-10-20       Impact factor: 2.628
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.